Role of Sox-9, ER81 and VE-cadherin in retinoic acid-mediated trans-differentiation of breast cancer cells.

Role of Sox-9, ER81 and VE-cadherin in retinoic acid-mediated trans-differentiation of breast cancer cells.
复制标题

DOI:
10.1371/journal.pone.0002714
复制
发表时间:
2008-07-16
期刊:
影响因子:
3.7
通讯作者:
Byers SW
Byers SW
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Endo Y;Deonauth K;Prahalad P;Hoxter B;Zhu Y;Byers SW

文献摘要

参考文献

被引文献

相似文献

发育、肿瘤生长和转移的许多方面都取决于提供足够的脉管系统。这可能是受调节的血管生成、循环内皮祖细胞的募集和/或血管转分化的结果。本研究表明,用视黄酸 (RA)(胚胎发生、癌症和其他疾病的重要调节剂)处理 SKBR-3 乳腺癌细胞,可刺激基质胶中网络的形成。与人脐静脉内皮细胞共培养的 SKBR-3 细胞经 RA 处理导致混合结构的形成。 RA 诱导许多内皮基因的表达,包括血管内皮 (VE) 钙粘蛋白。 RA 在许多其他乳腺癌细胞中也诱导了 VE-钙粘蛋白。我们发现 RA 诱导的 VE-钙粘蛋白是 RA 诱导的形态变化的原因。 RA 快速诱导 Sox-9 和 ER81 的表达,它们反过来在 VE-钙粘蛋白启动子上形成复合物,并且是 RA 介导 VE-钙粘蛋白转录调节所必需的。这些数据表明,RA可能促进内皮基因的表达,导致内皮样分化,或者提供一种机制,使循环的内皮祖细胞可以整合到生长的器官或肿瘤中。
Many aspects of development, tumor growth and metastasis depend upon the provision of an adequate vasculature. This can be a result of regulated angiogenesis, recruitment of circulating endothelial progenitors and/or vascular trans-differentiation. The present study demonstrates that treatment of SKBR-3 breast cancer cells with retinoic acid (RA), an important regulator of embryogenesis, cancer and other diseases, stimulates the formation of networks in Matrigel. RA-treatment of SKBR-3 cells co-cultured with human umbilical vein endothelial cells resulted in the formation of mixed structures. RA induces expression of many endothelial genes including vascular endothelial (VE) cadherin. VE-cadherin was also induced by RA in a number of other breast cancer cells. We show that RA-induced VE-cadherin is responsible for the RA-induced morphological changes. RA rapidly induced the expression of Sox-9 and ER81, which in turn form a complex on the VE-cadherin promoter and are required to mediate the transcriptional regulation of VE-cadherin by RA. These data indicate that RA may promote the expression of endothelial genes resulting in endothelial-like differentiation, or provide a mechanism whereby circulating endothelial progenitor cells could be incorporated into a growing organ or tumor.
DOI: 10.1101/gad.1017802
发表时间: 2002-11-01
影响因子: 10.5
作者:
Akiyama, H;Chaboissier, MC;de Crombrugghe, B
通讯作者: de Crombrugghe, B
DOI: 10.1128/mcb.17.4.2336
发表时间: 1997-04-01
影响因子: 5.3
作者:
Lefebvre, V;Huang, WD;deCrombrugghe, B
通讯作者: deCrombrugghe, B
DOI: 10.1016/0959-437x(94)90071-a
发表时间: 1994-08-01
影响因子: 4
作者:
LANGSTON, AW;GUDAS, LJ
通讯作者: GUDAS, LJ
DOI: 10.1038/sj.onc.1203563
发表时间: 2000-05-11
期刊: ONCOGENE
影响因子: 8
作者:
Lelièvre, E;Mattot, V;Soncin, F
通讯作者: Soncin, F
DOI: 10.1158/0008-5472.can-07-2706
发表时间: 2008-03-01
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Labelle, Myriam;Schnittler, Hans J.;Breier, Georg
通讯作者: Breier, Georg